Advice for Type 2 Newbies
Let David Mendosa calm your fears and guide you through the next steps.
When patients in clinical trials are assigned to one part or segment of a study, they are in study arms. One arm receives a different treatment from another.
Karen wrote me that “The only possible concern about benfo is that because it is fat soluble, it may be possible for a person to take too much (like vitamin A and D). 150 mg three times/day seems to be a standard recommended dose at this time, and yet in this published study the dosages were much higher.”
She was also surprised that the article says that “benfotiamine [is] commonly used in treatment of diabetic neuropathy.” They she realized that this study took place in Germany.
“Here in the U.S., benfotiamine is NOT commonly used,” she continued. “In fact at work, I don’t think I’ve ever run across ANY patient who is taking it – and I specifically ask people about what supplements they are taking. Nobody knows about benfo yet. Hopefully, this glaring gap will start to close quickly.”
With this new research I have no doubt that many people with diabetes will start taking benfotiamine.
< Previous 1 | Page 2 >
- Font size
- Email This
- Bookmark
- Thank you for your input
- Save
- RSS
- Report Abuse
What the community is saying...
The Link To The Vit C Article
Posted 10/01 Comments (1)
I am so sorry, I forgot to include that link in my...
